BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Boragen was formed to develop synthetic fungicides based on a group of boron-containing compounds. In 2022, the company split into three separate companies, 5Metis, Borah and Reactive Biosciences.
Boragen
Research Triangle Park, NC
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.